Botox wastage: New policy from Medicare

Why This Topic Matters

The policy affects how practices report drug administration and discarded amounts on claims, which can change billing workflow and reimbursement for costly single-use medications. It is especially relevant for urology practices managing Botox use and related coverage uncertainty.

Article Sections

1. Medicare policy update on discarded drugs

   Summarizes the Medicare guidance update and the broader claims-processing changes related to discarded amounts from single-use drugs and biologicals.

2. Botox billing example and claim reporting

   Describes how the policy affects billing workflow for Botox when multiple patients or a single patient are involved, along with the related claims-handling considerations.

3. Unlisted procedure reporting for bladder injection

   Discusses reporting considerations for the procedure itself when Botox is used in the urinary system and notes payer coverage variability.

4. Coverage issues and payer-specific policies

   Reviews the practical reimbursement concerns that can arise when coverage is uncertain and references carrier-specific medical-necessity policies.

5. Competitive Acquisition Program guidance

   Covers the separate Medicare claims-processing guidance applicable to the Competitive Acquisition Program and the related documentation expectations.